Bio Impact Capital LLC has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $540 Million distributed in 43 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Cullinan Oncology, Inc. with a value of $57.9M, Madrigal Pharmaceuticals, Inc. with a value of $33.3M, Zai Lab LTD with a value of $30.1M, Edgewise Therapeutics, Inc. with a value of $24.3M, and Lantheus Holdings, Inc. with a value of $22.7M.
Examining the 13F form we can see an decrease of $128M in the current position value, from $669M to 540M.
Bio Impact Capital LLC is based out at Cambridge, MA
Below you can find more details about Bio Impact Capital LLC portfolio as well as his latest detailed transactions.